| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 11.05.24 | Cardurion Pharmaceuticals, Inc.: Cardurion Pharmaceuticals Presents Positive Clinical Results from CARDINAL-HF Phase 2a Clinical Trial of PDE9 Inhibitor in Patients With Heart Failure | 984 | Business Wire | PDE9 inhibitor, CRD-740, demonstrated favorable safety profile and achieved statistical significance for the trial's primary endpoint, median increase in plasma cyclic guanosine monophosphate (cGMP)... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| TESLA | 3.799 |
| NVIDIA | 3.206 |
| RHEINMETALL | 2.044 |
| RENK GROUP | 1.779 |
| THYSSENKRUPP | 1.683 |
| STEYR MOTORS | 1.618 |
| BYD | 1.580 |
| BAYER | 1.563 |
| NEL | 1.457 |
| DEUTZ | 1.446 |
| TUI | 1.404 |
| VOLKSWAGEN | 1.231 |
| EVOTEC | 1.149 |
| NOVO NORDISK | 1.131 |
| MERCEDES-BENZ | 1.012 |
| XIAOMI | 945 |
| AMAZON | 936 |
| PUMA | 891 |
| PORSCHE AG | 874 |
| BASF | 860 |
| COMMERZBANK | 786 |
| DEUTSCHE BANK | 784 |
| NORDEX | 772 |
| AIXTRON SE | 729 |
| VONOVIA | 640 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
